MolDX Draft LCDs - (DL38143, DL38147, DL38155) Published for Review and Comments

The following three draft JEB MolDX Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI, and Territories) and 01312 (NV).

Medicare Coverage Database Number LCD Title
DL38143 MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease
DL38147 MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Unfavorable Intermediate Risk Disease
DL38155 Lab: Drug Interaction Testing

 

Comment Period: May 30, 2019 – July 15, 2019

Go to the CMS MCD to access Proposed LCDs not released to final LCDs.  

  • Locate/select relevant listed LCD title(s)

Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Draft LCDs webpage for email and mail specifics.

 

Last Updated May 16, 2019